Studies 2019-05-27T19:28:16+00:00

Project Title:   An open label randomised controlled trial of two versus three doses of Rotarix™ vaccine for boosting and longevity of vaccine immune responses in Zambia.

Acronym: ROVAS-2

Principal Investigator/

EDCTP Senior Fellow

Roma Chilengi

EDCTP PhD Student

Natasha Makbilo Laban

EDCTP MSc student

Adriace Chauwa

This is an investigator led study to explore the potential value of a third dose of rotavirus vaccination for improving vaccine responses and longer-term protection for immunized infants.

The study is registered at Pan African Clinical Trials Registry and is available via the link:

Enrolment status:        Completed 212

Current status:             Follow up

Funded by The European & Developing Countries Clinical Trials Partnership (EDCTP)